Ocugen (OCGN) Enterprise Value Growth (1y) (2015 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Ocugen | 452.01 Mn | 452.01 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | -43.18% |
| Jun 30, 2024 | 77.76% |
| Mar 31, 2024 | 65.59% |
| Dec 31, 2023 | 56.60% |
| Sep 30, 2023 | 47.37% |
| Jun 30, 2023 | 38.63% |
| Mar 31, 2023 | 40.88% |
| Dec 31, 2022 | 4.24% |
| Sep 30, 2022 | 5.35% |
| Jun 30, 2022 | 0.55% |
| Mar 31, 2022 | -189.72% |
| Dec 31, 2021 | -295.02% |
| Sep 30, 2021 | -461.86% |
| Jun 30, 2021 | -672.59% |
| Mar 31, 2021 | -1,302.82% |
| Dec 31, 2020 | -222.93% |
| Sep 30, 2020 | -24.87% |
| Jun 30, 2020 | -2,106.07% |
| Mar 31, 2020 | -934.28% |
| Dec 31, 2019 | -357.21% |
| Sep 30, 2019 | -516.05% |
| Jun 30, 2019 | 92.27% |
| Mar 31, 2019 | 98.01% |
| Dec 31, 2018 | 79.60% |
| Sep 30, 2018 | 80.32% |
| Jun 30, 2018 | 52.69% |
| Mar 31, 2018 | 36.38% |
| Dec 31, 2017 | 74.99% |
| Sep 30, 2017 | 66.79% |
| Jun 30, 2017 | -16.41% |
| Mar 31, 2017 | -6.45% |
| Dec 31, 2016 | -3.21% |
| Sep 30, 2016 | -0.72% |
| Jun 30, 2016 | 64.78% |
| Mar 31, 2016 | 56.95% |
| Dec 31, 2015 | 47.18% |
| Sep 30, 2015 | -1,057.86% |
| Jun 30, 2015 | -481.56% |
| Mar 31, 2015 | -1,482.77% |